| Product Code: ETC4472162 | Publication Date: Jul 2023 | Updated Date: Aug 2025 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 85 | No. of Figures: 45 | No. of Tables: 25 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) HIV Diagnosis Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) HIV Diagnosis Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) HIV Diagnosis Market - Industry Life Cycle |
3.4 United States (US) HIV Diagnosis Market - Porter's Five Forces |
3.5 United States (US) HIV Diagnosis Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 United States (US) HIV Diagnosis Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.7 United States (US) HIV Diagnosis Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United States (US) HIV Diagnosis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and education about HIV/AIDS leading to higher testing rates |
4.2.2 Technological advancements in diagnostic tools improving accuracy and efficiency of HIV diagnosis |
4.2.3 Government initiatives and funding to support HIV testing and diagnosis |
4.3 Market Restraints |
4.3.1 Stigma associated with HIV/AIDS leading to reluctance in seeking testing and diagnosis |
4.3.2 Cost barriers for individuals without insurance or limited healthcare coverage |
4.3.3 Limited access to testing facilities in rural or underserved areas |
5 United States (US) HIV Diagnosis Market Trends |
6 United States (US) HIV Diagnosis Market, By Types |
6.1 United States (US) HIV Diagnosis Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United States (US) HIV Diagnosis Market Revenues & Volume, By Product, 2021 - 2031F |
6.1.3 United States (US) HIV Diagnosis Market Revenues & Volume, By Consumables, 2021 - 2031F |
6.1.4 United States (US) HIV Diagnosis Market Revenues & Volume, By Instruments, 2021 - 2031F |
6.1.5 United States (US) HIV Diagnosis Market Revenues & Volume, By Software & Services, 2021 - 2031F |
6.2 United States (US) HIV Diagnosis Market, By Test Type |
6.2.1 Overview and Analysis |
6.2.2 United States (US) HIV Diagnosis Market Revenues & Volume, By Antibody Tests, 2021 - 2031F |
6.2.3 United States (US) HIV Diagnosis Market Revenues & Volume, By Viral Load Tests, 2021 - 2031F |
6.2.4 United States (US) HIV Diagnosis Market Revenues & Volume, By CD4 Tests, 2021 - 2031F |
6.2.5 United States (US) HIV Diagnosis Market Revenues & Volume, By Others, 2021 - 2031F |
6.3 United States (US) HIV Diagnosis Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 United States (US) HIV Diagnosis Market Revenues & Volume, By Diagnostic Laboratories, 2021 - 2031F |
6.3.3 United States (US) HIV Diagnosis Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.4 United States (US) HIV Diagnosis Market Revenues & Volume, By Others, 2021 - 2031F |
7 United States (US) HIV Diagnosis Market Import-Export Trade Statistics |
7.1 United States (US) HIV Diagnosis Market Export to Major Countries |
7.2 United States (US) HIV Diagnosis Market Imports from Major Countries |
8 United States (US) HIV Diagnosis Market Key Performance Indicators |
8.1 Percentage increase in the number of individuals getting tested for HIV annually |
8.2 Adoption rate of new diagnostic technologies in HIV testing facilities |
8.3 Number of government-funded programs aimed at promoting HIV testing and diagnosis |
8.4 Average turnaround time for receiving HIV test results |
8.5 Percentage of population with access to HIV testing facilities |
9 United States (US) HIV Diagnosis Market - Opportunity Assessment |
9.1 United States (US) HIV Diagnosis Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 United States (US) HIV Diagnosis Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.3 United States (US) HIV Diagnosis Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United States (US) HIV Diagnosis Market - Competitive Landscape |
10.1 United States (US) HIV Diagnosis Market Revenue Share, By Companies, 2024 |
10.2 United States (US) HIV Diagnosis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here